close
MENU
2 mins to read

Ebos eyes Australian retail pharmacy with Terry White deal

Ebos is selling its 270-store Chemmart business to Terry White Group.

Paul McBeth
Thu, 04 Aug 2016

Ebos Group plans to beef up its Australian retail pharmacy exposure selling its 270-store Chemmart business to Terry White Group and taking a 50% stake in the enlarged pharmacy chain.

The deal is subject to several conditions including Terry White Group shareholder approval and is expected to be wrapped up in late October, Christchurch-based Ebos said in a statement. Once completed, Terry White Group's retail network will expand to 500 and its financial statements will be consolidated into Ebos' accounts. The New Zealand company will receive shares for the sale of Chemmart's assets and inject an undisclosed amount of new capital to lift its stake to 50%, with chief executive Patrick Davies taking a seat on the board.

Ebos said the expected earnings impact isn't material, with retail pharmacy accounting for about 6% of its gross operating revenue.

"The pharmacy industry is positioned for growth with Australia's ageing population and positive community attitudes towards health and wellbeing," Mr Davies said. "This merger is about capitalising on those strengths and continuing to develop competitive and sustainable businesses for pharmacy owners while also significantly increasing our ability to meet the evolving needs of our customers."

Earlier this year,Mr  Davies said Ebos' businesses were spitting out enough cash to allow for more acquisitions while meeting its policy of paying 60-70% percent of net profit in dividends. The company transformed itself in 2013 with the purchase of Australian pharmaceutical wholesaler and distributor Symbion, and has since bought New Zealand vitamin and herbal tea maker Red Seal, pharmaceuticals firm Zest, Australian pharmacy retailer Good Price Pharmacy Warehouse and the BlackHawk Premium Pet Care pet food business.

Brisbane-headquartered Terry White Group reported a profit of $A1.5 million from continuing operations on a 44% increase in revenue to $A32.9 million in the six months ended December 31. It told shareholders in the unlisted company it expected annual earnings before interest, tax, depreciation and amortisation to be "significantly higher" than the $A3.7 million posted in 2015 and was "committed to the expansion of the network and would continue to explore growth opportunities in 2016 and beyond."

In a separate statement, Terry White Group said shareholders will vote on the proposal at a special meeting next month.

Terry White Group chief executive Andrew White will lead the enlarged franchise management entity, with Ebos's Chemmart executive director, Duncan Phillips, taking the role of chief operating officer.

Terry White Group chairman Terry White recommended the deal to shareholders, saying the board will be voting in favour of the transaction.

Ebos shares were unchanged at $16.50, and have gained 20% this year.

(BusinessDesk)

Click the hamburger symbol top right of our homepage to access the Rich List 2016 and other sections.

Paul McBeth
Thu, 04 Aug 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos eyes Australian retail pharmacy with Terry White deal
60480
false